{
  "ptid_time": "041_S_5097_2014-03-17",
  "img_path": "/data/qiuhui/data/adni/images/041_S_5097/2014-03-17/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 39,886 mm³, 32.8% above the reference mean. With a Z-score of 0.78 (78.2th percentile), this represents normal volume ; hippocampal volume measures 6,151 mm³, 23.4% below the reference mean. With a Z-score of -2.34 (1.0th percentile), this represents significant atrophy; whole brain volume measures 997,134 mm³, 12.1% below the reference mean. With a Z-score of -1.71 (4.3th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,168 mm³, 25.7% below the reference mean. With a Z-score of -1.78 (3.8th percentile), this represents moderate atrophy; fusiform gyrus volume measures 13,785 mm³, 30.8% below the reference mean. With a Z-score of -2.56 (0.5th percentile), this represents significant atrophy; middle temporal gyrus volume measures 17,031 mm³, 24.0% below the reference mean. With a Z-score of -1.98 (2.4th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 68.5 years. Gender is Male. Education: 16 years. MMSE: 29.0. MoCA: 22.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus and fusiform gyrus, along with moderate atrophy in the whole brain, entorhinal cortex, and middle temporal gyrus—all regions strongly implicated in Alzheimer's disease. Despite a normal MMSE (29/30), the MoCA (22/30) suggests mild cognitive impairment, and the absence of APOE4 does not rule out neurodegeneration given the structural findings.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amnestic subtype given hippocampal atrophy).  \n**Confidence:** **High** (due to concordance between imaging atrophy patterns and MoCA performance, though clinical progression should be monitored for conversion to dementia).  \n\n*Note: The discrepancy between MMSE (insensitive to early deficits) and MoCA (more sensitive to MCI) reinforces the diagnosis. The lack of APOE4 lowers Alzheimer’s probability but does not exclude it, as ~40% of AD patients are APOE4-negative.*",
  "timestamp": "2025-07-26T07:25:16.603150"
}